Ergosterol distribution controls surface structure formation and fungal pathogenicity
mBio · 06.07.2023
DOI: 10.1128/mbio.01353-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, online erschienen am 06.07.2023. Verfasst von Hau Lam Choy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Cryptococcosis, Cryptococcus neoformans. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Ergosterol, the major sterol in fungal membranes, is critical for defining membrane fluidity and regulating cellular processes. Although ergosterol synthesis has been well defined in model yeast, little is known about sterol organization in the context of fungal pathogenesis. We identified a retrograde sterol transporter, Ysp2, in the opportunistic fungal pathogen Cryptococcus neoformans . We found that the lack of Ysp2 under host-mimicking conditions leads to abnormal accumulation of ergosterol at the plasma membrane, invagination of the plasma membrane, and malformation of the cell wall, which can be functionally rescued by inhibiting ergosterol synthesis with the antifungal drug fluconazole. We also observed that cells lacking Ysp2 mislocalize the cell surface protein Pma1 and have abnormally thin and permeable capsules. As a result of perturbed ergosterol distribution and its consequences, ysp2 ∆ cells cannot survive in physiologically relevant environments such as host phagocytes and are dramatically attenuated in virulence. These findings expand our knowledge of cryptococcal biology and underscore the importance of sterol homeostasis in fungal pathogenesis. IMPORTANCE Cryptococcus neoformans is an opportunistic fungal pathogen that kills over 100,000 people worldwide each year. Only three drugs are available to treat cryptococcosis, and these are variously limited by toxicity, availability, cost, and resistance. Ergosterol is the most abundant sterol in fungi and a key component in modulating membrane behavior. Two of the drugs used for cryptococcal infection, amphotericin B and fluconazole, target this lipid and its synthesis, highlighting its importance as a therapeutic target. We discovered a cryptococcal ergosterol transporter, Ysp2, and demonstrated its key roles in multiple aspects of cryptococcal biology and pathogenesis. These studies demonstrate the role of ergosterol homeostasis in C. neoformans virulence, deepen our understanding of a pathway with proven therapeutic importance, and open a new area of study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA.
ORCID-Profile: Hau Lam Choy, Elizabeth A Gaylord, Tamara L Doering
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- HHS | NIH | National Institute of General Medical Sciences
Zitieren
APA
Choy, H. L., Gaylord, E. A., & Doering, T. L. (2023). Ergosterol distribution controls surface structure formation and fungal pathogenicity. mBio. https://doi.org/10.1128/mbio.01353-23
Vancouver
Choy HL, Gaylord EA, Doering TL. Ergosterol distribution controls surface structure formation and fungal pathogenicity. mBio. 2023. doi:10.1128/mbio.01353-23
BibTeX
@article{Choy2023,
author = {Choy, Hau Lam and Gaylord, Elizabeth A and Doering, Tamara L},
title = {Ergosterol distribution controls surface structure formation and fungal pathogenicity},
journal = {mBio},
year = {2023},
doi = {10.1128/mbio.01353-23}
}
EUVIMED